Alosetron Hydrochloride Patent Expiration
Alosetron Hydrochloride is Used for treating severe diarrhea-predominant irritable bowel syndrome (IBS) in women. It was first introduced by Sebela Ireland Ltd
Alosetron Hydrochloride Patents
Given below is the list of patents protecting Alosetron Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Lotronex | US6284770 | Medicaments for the treatment of non-constipated female irritable bowel syndrome |
Oct 05, 2018
(Expired) | Sebela Ireland Ltd |
| Lotronex | US5360800 | Tetrahydro-1H-pyrido[4,3-b]indol-1-one derivatives |
Jan 13, 2013
(Expired) | Sebela Ireland Ltd |
Alosetron Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Alosetron Hydrochloride Generic API Manufacturers
Several generic applications have been filed for Alosetron Hydrochloride. The first generic version for Alosetron Hydrochloride was by Hikma Pharmaceuticals Usa Inc and was approved on May 4, 2015. And the latest generic version is by Mankind Pharma Ltd and was approved on Sep 9, 2020.
Given below is the list of companies who have filed for Alosetron Hydrochloride generic, along with the locations of their manufacturing plants worldwide.
1. AMNEAL PHARMS
Amneal Pharmaceuticals Of New York Llc has filed for 2 different strengths of generic version for Alosetron Hydrochloride. Given below are the details of the strengths of this generic introduced by Amneal Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1MG BASE | tablet | Prescription | ORAL | AB | Dec 22, 2016 |
| EQ 0.5MG BASE | tablet | Prescription | ORAL | AB | Dec 22, 2016 |
2. ENDO OPERATIONS
Endo Operations Ltd has filed for 2 different strengths of generic version for Alosetron Hydrochloride. Given below are the details of the strengths of this generic introduced by Endo Operations.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1MG BASE | tablet | Discontinued | ORAL | N/A | Feb 23, 2018 |
| EQ 0.5MG BASE | tablet | Discontinued | ORAL | N/A | Feb 23, 2018 |
3. HIBROW HLTHCARE
Hibrow Healthcare Private Ltd has filed for 2 different strengths of generic version for Alosetron Hydrochloride. Given below are the details of the strengths of this generic introduced by Hibrow Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.5MG BASE | tablet | Discontinued | ORAL | N/A | Sep 16, 2019 |
| EQ 1MG BASE | tablet | Discontinued | ORAL | N/A | Sep 16, 2019 |
4. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Alosetron Hydrochloride. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.5MG BASE | tablet | Discontinued | ORAL | N/A | May 4, 2015 |
| EQ 1MG BASE | tablet | Discontinued | ORAL | N/A | May 4, 2015 |
Manufacturing Plant Locations New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||
| Portugal |
| |||||||||
| Jordan |
| |||||||||
5. MANKIND PHARMA
Mankind Pharma Ltd has filed for 2 different strengths of generic version for Alosetron Hydrochloride. Given below are the details of the strengths of this generic introduced by Mankind Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.5MG BASE | tablet | Prescription | ORAL | AB | Sep 9, 2020 |
| EQ 1MG BASE | tablet | Prescription | ORAL | AB | Sep 9, 2020 |
Manufacturing Plant Locations New
Mankind Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Mankind Pharma as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| India |
| |||||
6. RISING
Rising Pharma Holdings Inc has filed for 2 different strengths of generic version for Alosetron Hydrochloride. Given below are the details of the strengths of this generic introduced by Rising.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 0.5MG BASE | tablet | Prescription | ORAL | AB | Jan 14, 2019 |
| EQ 1MG BASE | tablet | Prescription | ORAL | AB | Jan 14, 2019 |
Manufacturing Plant Locations New
Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||
| Mexico |
| |||||||||||||||||||
| India |
| |||||||||||||||||||